• P-ISSN1225-0163
  • E-ISSN2288-8985
  • SCOPUS, ESCI, KCI

Article Detail

Home > Article Detail
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

Bioconjugation by dual heterobifunctional coupling method:Use of the conjugates for the detection of dopamine

Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
2010, v.23 no.6, pp.537-543
https://doi.org/10.5806/AST.2010.23.6.537


  • Downloaded
  • Viewed

Abstract

Dopamine (DA) is an important neurotransmitter molecule of catecholamines. Its deficiency could lead to brain disorder such as Parkinson's disease and schizophrenia. Therefore, it is necessary to establish a suitable analytical technique with sensitivity and simplicity. A competitive enzyme-linked immunosorbent assay for DA has been optimized and characterized. Assay sensitivity is controlled by two factors in competitive immunoassay. One is a nature and concentration of competitor, and the other is those of binder, antibody. Thus,optimization was performed: BSA-DA conjugate and antibody-avidin conjugate were prepared by dual heterobifunctional coupling method using SATA and SMCC. Assay condition was optimized with 6.66 μgmL−1 of BSA-DA and 4.17×10−10 M of antibody-avidin conjugate. A dose-response curve was constructed, and a limit of detection and a dynamic range for DA were accomplished to 2.3×10−2 μg mL−1 and four orders of magnitude (1.0×10−7 M to 1.0×10−3 M), respectively. Calibration curve was constructed on dynamic range and least-squares regression of this data gave the following relationship: absorbance = -0.1098 log[DA]+0.0353 (R2 = 0.9956).

keywords
immunoassay, dopamine, heterobifunctional coupling, avidin/biotin


Reference

1

1. P. Damier, E. C. Hirsch, Y. Agid and A. M. Grzaybiel, Brain, 122, 1437-1448(1999).

2

2. T. Selvaraju and R. Ramaraj, Electrochem. Commun., 5, 667-672(2003).

3

3. T. Hussain and M. F. Lokhandwala, Exp. Biol. Med. 228, 134-142(2003).

4

4. P. A. Jose, G. M. Eisner and R. A. Felder, Pharm. Therap., 80, 149-182(1998).

5

5. G. Ivan, N. Szigeti-Csucs, M. Olah, G.M. Nagy and M. I. Goth, Endocrine, 28, 101-110(2005).

6

6. T. Kienast and A. Heinz, CNS Neurol. Disord. Drug Targets, 5, 109-131(2006).

7

7. Q. Li, J. Li and Z. Yang, Anal. Chim. Acta, 583, 147- 152(2007).

8

8. S. Thiagarajan and S. M. Chen, Talanta, 74, 212- 222(2007).

9

9. J. Kim, H. Park, J. Ryu, O. Jeon and I. R. Paeng, J. Immunoass. Immunochem., 31, 33-44(2010).

10

10. J. Kim, M. Jeon, K.-J. Paeng and I. R. Paeng, Ana. Chim. Acta., 619, 87-93(2008).

11

11. V. Carrera, E. Sabater, E. Vilanova and M. A. Sogorb, J. Chromatogr. B, 847, 88-94(2007).

12

12. M. Jeon and I. R. Paeng, Ana. Chim. Acta., 619, 180- 185(2008).

13

13. M. Jeon, J. Kim, K.-J. Paeng, S.-W. Park and I. R. Paeng, Microchem. J., 88, 26-31(2008).

14

14. S. Shrestha, I. R. Paeng, S. K. Deo, and S. Daunert, Bioconjugate Chem., 13, 269-275(2002).

15

15. D. Wild, Immunoassay Handbook, 2nd ed Nature Publishing Group, U.K. 2001.

16

16. A. E. Sanchez-Rivera, S. Corona-Avendano, G. Alarcon- Angeles, A.Rojas-Hernandez, M. T. Ramirez-Silva and M. A. Romero-Romo, Spectrochim. Acta A., 59, 3193-3203(2003).

17

17. J. Zheng and X. Zhou, Bioelectrochemistry, 70, 408- 415(2007).

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Analytical Science and Technology